Richard I Steinhart - Net Worth and Insider Trading
Richard I Steinhart Net Worth
The estimated net worth of Richard I Steinhart is at least $9,294 dollars as of 2024-11-29. Richard I Steinhart is the CFO of BioXcel Therapeutics Inc and owns about 20,279 shares of BioXcel Therapeutics Inc (BTAI) stock worth over $9,174. Richard I Steinhart is also the Director of Actinium Pharmaceuticals Inc and owns about 83 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $120. Details can be seen in Richard I Steinhart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard I Steinhart has not made any transactions after 2024-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard I Steinhart
Richard I Steinhart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard I Steinhart owns 5 companies in total, including Actinium Pharmaceuticals Inc (ATNM) , BioXcel Therapeutics Inc (BTAI) , and Atossa Therapeutics Inc (ATOS) among others .
Click here to see the complete history of Richard I Steinhart’s form 4 insider trades.
Insider Ownership Summary of Richard I Steinhart
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals Inc | 2016-04-14 | director |
| BTAI | BioXcel Therapeutics Inc | 2024-10-03 | Chief Financial Officer |
| ATOS | Atossa Therapeutics Inc | 2014-03-01 | director |
 | | 2006-04-24 | Chief Financial Officer |
| | 2010-03-03 | director |
Richard I Steinhart Latest Holdings Summary
Richard I Steinhart currently owns a total of 2 stocks. Among these stocks, Richard I Steinhart owns 20,279 shares of BioXcel Therapeutics Inc (BTAI) as of October 3, 2024, with a value of $9,174 and a weighting of 98.71%. Richard I Steinhart also owns 83 shares of Actinium Pharmaceuticals Inc (ATNM) as of April 14, 2016, with a value of $120 and a weighting of 1.29%.
Latest Holdings of Richard I Steinhart
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2024-10-03 | 20,279 | 0.45 | 9,174 |
| ATNM | Actinium Pharmaceuticals Inc | 2016-04-14 | 83 | 1.44 | 120 |
Holding Weightings of Richard I Steinhart
Richard I Steinhart Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard I Steinhart has made a total of 7 transactions in BioXcel Therapeutics Inc (BTAI) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in BioXcel Therapeutics Inc is the sale of 7,175 shares on October 3, 2024, which brought Richard I Steinhart around $3,946.
According to the SEC Form 4 filings, Richard I Steinhart has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 83 shares on April 14, 2016, which cost Richard I Steinhart around $5,025.
Insider Trading History of Richard I Steinhart
- 1
Richard I Steinhart Trading Performance
GuruFocus tracks the stock performance after each of Richard I Steinhart's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard I Steinhart is 56.28%. GuruFocus also compares Richard I Steinhart's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard I Steinhart within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard I Steinhart's insider trading performs compared to the benchmark.
Performance of Richard I Steinhart
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.87 | | | | | |
| Relative Return to S&P 500(%) | -3.58 | | | | | |
Richard I Steinhart Ownership Network
Richard I Steinhart Owned Company Details
What does Actinium Pharmaceuticals Inc do?
Who are the key executives at Actinium Pharmaceuticals Inc?
Richard I Steinhart is the director of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include VP & Finance and Corporate Dev. Steve O'loughlin , Chief Scientific Officer Dale L. Ludwig , and Chief Commercial Officer Anil Kapur .
Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Actinium Pharmaceuticals Inc Insider Transactions
Richard I Steinhart Mailing Address
Above is the net worth, insider trading, and ownership report for Richard I Steinhart. You might contact Richard I Steinhart via mailing address: 125 Elm Street, New Canaan Ct 06840.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
